Mark For: FMI® trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 88274983 |
Registration Number | 1500026 |
Mark Literal Elements | FMI |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | SERVICE MARK |
Register | PRINCIPAL |
Current Location | INTENT TO USE SECTION 2020-06-30 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Douglas R. Wolf |
Attorney Docket Number | F067820030US |
Law Office Assigned | L70 |
Employee Name | HAN, DAWN L |
2018-02-00 | Date of First Use |
2019-01-24 | Application Filed |
2019-08-26 | Location: TMEG LAW OFFICE 107 - EXAMINING ATTORNEY ASSIGNED |
2019-08-26 | Status: Live/Pending |
2019-11-28 | Transaction Date |
2020-05-05 | Published |
2020-06-30 | Location: INTENT TO USE SECTION |
2020-06-30 | Status: Notice of Allowance (NOA) sent (issued) to the applicant. Applicant must file a Statement of Use or Extension Request within six |
Party: | Foundation Medicine, Inc. |
Address | 150 Second Street Cambridge, MASSACHUSETTS UNITED STATES 02141 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
Drawing | IMAGE/JPEG | 2019-01-24 |
TEAS RF New Application | APPLICATION/XML,IMAGE/JPEG | 2019-01-24 |
XSearch Search Summary | XML | 2019-04-06 |
Offc Action Outgoing | XML | 2019-04-15 |
Response to Office Action | MULTI | 2019-05-31 |
Amendment and Mail Process Complete | APPLICATION/XML,IMAGE/JPEG | 2019-06-01 |
Offc Action Outgoing | XML | 2019-06-27 |
Amendment to Allege Use | MULTI | 2019-07-23 |
Specimen | JPEG | 2019-07-23 |
TEAS Request Reconsideration after FOA | XML | 2019-07-23 |
AAU Processing Complete | MULTI | 2019-07-30 |
Amendment and Mail Process Complete | MULTI | 2019-07-30 |
Accept-AAU-Notice | 2019-08-26 | |
Offc Action Outgoing | XML | 2019-08-26 |
Notice of Acceptance of AAU | XML | 2019-08-27 |
Examiners Amendment | XML | 2020-02-26 |
Amendment and Mail Process Complete | APPLICATION/XML,IMAGE/JPEG | 2020-02-27 |
TRAM Snapshot of App at Pub for Oppostn | APPLICATION/XML,IMAGE/JPEG | 2020-04-03 |
Notice of Publication | XML | 2020-04-15 |
Notification Of Notice of Publication | XML | 2020-04-15 |
OG Publication Confirmation | APPLICATION/XML | 2020-05-05 |
Notice of Allowance | APPLICATION/XML | 2020-06-30 |
IC 042. US 100 101. G & S: providing an online Internet website portal featuring links to scientific research data and information in the field of cancer treatment and diagnosis and clinical trials; providing collected and analyzed medical and scientific research information in the field of cancer genomics and cancer treatment
IC 044. US 100 101. G & S: providing an Internet website portal featuring information on patient medical test results from medical testing for diagnosis or treatment purposes; providing an Internet website portal featuring links to medical information; genomic and genetic and molecular medical testing for cancer diagnostic or treatment purposes; providing collected and analyzed medical information on cancer genomics and treatment; providing collected and analyzed medical information on cancer genomics and treatment, for diagnostic and treatment purposes; medical testing for cancer diagnostic or treatment purposes; providing medical information and data to healthcare professionals on cancer genomics and treatment and clinical trials; providing medical information featuring the collection and analysis of cancer-associated genetics and treatments; providing medical data to healthcare professionals on cancer genomics and treatments and clinical trials
International Codes: | 42 |
U.S. Codes: | 100,101 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0421 | providing an online Internet website portal featuring links to scientific research data and information in the field of cancer treatment and diagnosis and clinical trials; providing collected and analyzed medical and scientific research information in the field of cancer genomics and cancer treatment |
Description | Date | Proceeding Number |
---|---|---|
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2020-06-30 | |
PUBLISHED FOR OPPOSITION | 2020-05-05 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-05-05 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-04-15 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-04-02 | |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2020-02-26 | 6328 |
EXAMINERS AMENDMENT E-MAILED | 2020-02-26 | 6328 |
EXAMINERS AMENDMENT -WRITTEN | 2020-02-26 | 78428 |
EXAMINER'S AMENDMENT ENTERED | 2020-02-26 | 88888 |
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED | 2019-08-27 | |
USE AMENDMENT ACCEPTED | 2019-08-26 | 78428 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-08-26 | 6325 |
NON-FINAL ACTION WRITTEN | 2019-08-26 | 78428 |
NON-FINAL ACTION E-MAILED | 2019-08-26 | 6325 |
USE AMENDMENT FILED | 2019-07-29 | 70629 |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-07-29 | 70629 |
ASSIGNED TO LIE | 2019-07-29 | 70629 |
AMENDMENT TO USE PROCESSING COMPLETE | 2019-07-29 | 70629 |
TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2019-07-23 | |
TEAS AMENDMENT OF USE RECEIVED | 2019-07-23 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-07-23 | 70629 |
NOTIFICATION OF FINAL REFUSAL EMAILED | 2019-06-27 | |
FINAL REFUSAL WRITTEN | 2019-06-27 | 78428 |
FINAL REFUSAL E-MAILED | 2019-06-27 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-05-31 | 88889 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-05-31 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-05-31 | 88889 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-04-15 | 6325 |
NON-FINAL ACTION WRITTEN | 2019-04-15 | 78428 |
NON-FINAL ACTION E-MAILED | 2019-04-15 | 6325 |
ASSIGNED TO EXAMINER | 2019-04-05 | 78428 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-02-15 | |
NEW APPLICATION ENTERED IN TRAM | 2019-01-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.